For the fiscal year ended September 30, 2025, our revenues generated from sales to pharmaceutical distributors, hospitals, clinics and drugstore chains represented 46.41%, 13.16%, 0.74%, and 39.69% o…
For the fiscal year ended September 30, 2025, our revenues generated from sales to pharmaceutical distributors, hospitals, clinics and drugstore chains represented 46.41%, 13.16%, 0.74%, and 39.69% o…
For the fiscal year ended September 30, 2025, our revenues generated from sales to pharmaceutical distributors, hospitals, clinics and drugstore chains represented 46.41%, 13.16%, 0.74%, and 39.69% o…
For the fiscal year ended September 30, 2025, our revenues generated from sales to pharmaceutical distributors, hospitals, clinics and drugstore chains represented 46.41%, 13.16%, 0.74%, and 39.69% o…
Universe Pharmaceuticals INC Debt Obligations
Instrument
Description
Confidence
Evidence
UPC-DEBT-13230
Warrants outstanding: 0.001
90%
xbrl warrant detail from xbrl 2023-03-31.
UPC-DEBT
Debt stack $9.3M
90%
Market cache reports total debt of $9.3M.
Universe Pharmaceuticals INC Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Universe Pharmaceuticals INC.
Universe Pharmaceuticals INC Ownership
No ownership data on recordNo major institutional ownership relationships found in our database for Universe Pharmaceuticals INC.